Sir Jonathan Symonds, CBE, was appointed as Deputy Group Chairman of HSBC Holdings plc in August 2018, as senior independent non-executive Director in April 2017 and has been an independent non-executive Director since April 2014. He has extensive international financial and governance experience.

Sir Jonathan was previously Chairman of HSBC Bank plc, HSBC’s European subsidiary, which offers services to clients in the UK and Continental Europe.

He was Chief Financial Officer of Novartis AG from 2009 to 2013. Before joining Novartis he was a Partner and Managing Director of Goldman Sachs; Chief Financial Officer of AstraZeneca plc; and a Partner at KPMG. His governance experience includes roles as non-executive Director and chair of the audit committees of Diageo plc and QinetiQ plc.

He is currently non-executive Chairman of GlaxoSmithKline plc, Chairman of Proteus Digital Health Inc. and of Genomics England Limited. He is also a non-executive director of Rubius Therapeutics, Inc.

Sir Jonathan is a Fellow of the Institute of Chartered Accountants in England and Wales. He has a BA, First Class Honours in Business Finance from the University of Hertfordshire.

News and insight

Inspiring future coders

HSBC is helping girls and young women develop tech skills through a new partnership.

HSBC tops trade finance poll

The bank has been named the global market leader in trade finance for the third year running.

Consumers carry the global economy

Consumer spending will be key to global growth during the next two years, says HSBC’s Janet Henry.